Background: Liver functions and portosystemic collaterals influence the development and severity of hepatic encephalopathy (HE) in cirrhosis. However, it has not been examined which factor has a greater influence or if shunts can be used to determine the presence and severity of HE. The expression of tumor necrosis factor-a (TNF-a) is increased in cirrhosis, and its role in HE deserves further evaluation. Methods: Portal hypertension was induced by portal vein ligation (PVL; a model of high-degree portosystemic shunting without significant liver damage) and liver cirrhosis was induced by bile duct ligation (BDL; a model of low-degree shunting with liver cirrhosis) in male SpraqueDawley rats. Sham-operated rats were used as controls. Motor activity counts, hemodynamic parameters, plasma levels, liver biochemistry parameters, TNF-a, and a flow-pressure curve study of portosystemic collaterals (where a higher slope indicates fewer portosystemic collaterals) were performed on Day 7 after PVL and Week 5 after BDL. Results: Portal pressure was significantly higher in the PVL and BDL groups than in controls. The liver biochemistry parameters, TNF-a, and motor activities were not significantly different between the PVL and PVL-control groups. In the BDL group, TNF-a, AST, and total bilirubin levels were significantly higher and the motor activity counts were lower than in the BDL-control group. Moreover, in the BDL rats, TNFa ( p ¼ 0.037, R ¼ -0.490), AST ( p ¼ 0.007, R ¼ -0.595) and total bilirubin (P ¼ 0.001, R ¼ À0.692) levels, but not the slopes of the flowpressure curves, were significantly and negatively correlated with the motor activity counts. Conclusion: The presence of a high degree of portosystemic shunting without significant liver damage may not be adequate for the development of HE.
Introduction
Hepatic encephalopathy (HE) is a neuropsychiatric disorder the encompasses a broad spectrum of symptoms that may vary from subtle mental changes in the early stages to the complete loss of consciousness (i.e., hepatic coma) in the late stages. 1 Numerous substances have been shown to be involved in the pathogenesis of HE. 2 Among these toxic substances, the most widely studied is ammonia, which is mainly synthesized by bacteria in the intestines and carried by portal venous blood to the liver for further metabolism.
The presence of portosystemic collaterals is a well-known feature of portal hypertension. 3 Collaterals develop as a response to increased portal pressure; they divert the portal tributary blood flow into systemic circulation in order to decompress the pressurized portal system. Previous studies have reported that increased blood and brain ammonia concentrations can induce encephalopathy in portacavalshunted rats, but not in sham-operated rats. 4 Moreover, portacaval-shunted rats have higher concentrations of brain glutamine, aromatic amino acids, cerebrospinal fluid glutamine, aromatic amino acids, glutamate, and aspartate compared with sham-operated rats. 4 These results indicate that hyperammonemia alone does not induce encephalopathy, whereas portosystemic collaterals are essential to the pathogenesis of encephalopathy. In a portal hypertensive state, ammonia may bypass the liver directly into systemic circulation in the form of collaterals and consequently cause neurobehavior changes. Furthermore, it is possible that the higher the degree of portosystemic shunting, the greater the amount of ammonia that is shunted directly into systemic circulation. However, whether the degree of shunting per se determines the presence and severity of encephalopathy is unknown.
Tumor necrosis factor-a (TNF-a) is a proinflammatory cytokine that is released into the bloodstream upon the recognition of bacterial products by the monocyte CD14 receptor and is essential for an adequate host response against infection. 5 It has been shown that TNF-a participates in the development of hyperdynamic circulatory syndrome and hepatopulmonary syndrome in cirrhotic rats. 6 We have also demonstrated that cirrhotic rats with ascites have increased plasma levels of TNF-a. 7 Regarding the involvement of TNFa in the pathogenesis of HE, cerebral inflammatory responses have been proposed to be the major cause of bile duct ligation (BDL; i.e., an animal model of liver cirrhosis)-induced HE. This is supported by a report that peripheral TNF-a-secreting monocytes can infiltrate the brain on Day 10 after BDL. 8 Although we have previously found that there is no correlation between TNF-a and the severity of HE, as assessed by motor activity counts and plasma levels of TNF-a in rats with thioacetamide-induced acute liver failure, 9 the relationship between TNF-a and HE in cirrhosis and portal hypertension deserves further evaluation.
In this study, we used two animal models: partially portal vein-ligated (PVL; high shunting model) rats, 3 in which more than 90% of the portal venous blood is shunted directly into systemic circulation without significant liver damage, and BDL (low shunting model)-induced cirrhotic rats, 10, 11 in which both liver failure and collaterals are present, in order to investigate the relationship between liver function, the circulating concentration of TNF-a, degree of portosystemic shunting, and changes in motor activities that occur in portal hypertensive rats with or without liver injury.
Methods

PVL model
PVL rats were used as described in a previous report. 12 Male Sprague-Dawley rats weighing 280e300 g at the time of surgery were used in these experiments. Ketamine HCl (100 mg/kg-body weight, intramuscularly administered) was used as the anesthesia. In brief, the portal vein was isolated and a 3-0 silk ligature was tied around both the portal vein and an adjacent 20-gauge, blunt-tipped needle. The needle was then removed and the vein was allowed to re-expand. A second, loose ligature was left around the portal vein with the two endings of the ligature were placed on each side of the abdominal cavity. The abdomen was then closed and the animal was allowed to recover. The body weights of rats were measured on the day of the experiments.
BDL model
Male Sprague-Dawley rats weighing 240e270 g at the time of surgery were used for experiments. A common bile duct (CBD) division and occluded animal model was created, as described in previous reports. 10, 11 In brief, the rats were anesthetized with ketamine (100 mg/kg-body weight, intramuscularly administered), and then the CBD was exposed and ligated using two 3-0 silk sutures. The first ligature was made below the junction of the intrahepatic bile ducts, and the second ligature was made above the entrance to the pancreatic ducts. Then, the CBD was catheterized by insertion of a PE-10 catheter, and 10% formalin (100 mL/100g) was slowly injected into the biliary tree in order to prevent the subsequent dilatation of the ligated bile ducts. 13 Finally, the CBD was transected by the two ligatures. Benzathine benzylpenicillin was postoperatively administered (50,000 units, intramuscularly administered) to prevent infection. Vitamin K (8 mg/kg-body weight, intramuscularly administered) was administered after surgery at weekly intervals. The animals were allowed to recover and then studied 5 weeks after surgery.
All of the rats in each animal model were housed in plastic cages and allowed free access to food and water. They were fasted for 12 hours prior to surgery. The body weights of the rats were measured on the day of the experiment. This study was approved by Taipei Veterans General Hospital Animal Committee. In addition, the principles of laboratory animal care (Guide for the Care and Use of Laboratory Animals, DHEW publication no.
[NIH] 85-23, rev. 985, Office of Science and Health Reports, DRR/NIH, Bethesda, MD 20205, USA) were followed throughout all experiments.
Experimental design
Several parameters were measured, including spontaneous motor activity counts (total, ambulatory, and vertical), mean arterial pressure (MAP), portal pressure (PP), and heart rate (HR), and flow-pressure curve studies were performed in the PVL rats 7 days after surgery and in the BDL rats 5 weeks after surgery. After measurement of the motor activities using an Opto-Varimex animal activity meter (Columbus Instruments, Inc., Columbus, OH, USA), 14 MAP, PP, and HR were measured in each rat. Blood was collected before the flowpressure curve studies were performed. The blood samples were separated in a refrigerated centrifuge at 4 C and 2935 g for 10 minutes, then stored at À70 C in pyrogen-free polyethylene tubes for subsequent analysis within 6 weeks. TNF-a and liver biochemistry tests (alanine aminotransferase [ALT], aspartate aminotransferase [AST], and total bilirubin) were performed. The flow-pressure curve study was performed by in situ collateral perfusion. The slope of the flow-pressure curve represents the overall resistance of the portosystemic collaterals to the perfusion flow and was used as an index of the degree of portosystemic shunting. Correlations between motor activity counts, liver biochemistry parameters, and the degree of portosystemic shunting were determined. Rats that received sham operation served as controls. Since no portosystemic collaterals developed in the sham-operated rats, they were analyzed for all of the aforementioned parameters except the flow-pressure curve study.
Measurement of spontaneous motor activities
In the open field, the total, ambulatory, and vertical motor activity counts were measured using the Opto-Varimex animal activity meter (Columbus Instruments, Inc., Columbus, OH, USA) 14 for 30 minutes. The Opto-Varimex activity sensors utilize high-intensity, modulated, infrared light beams to detect animal motion. Animals were housed in transparent cages (17 inches Â 17 inches Â 8 inches) through which 30 infrared beams were passed through the horizontal plane, 15 through each axis. This device is able to differentiate between nonambulatory (e.g., scratching, gnawing, etc.) and ambulatory movements based on the number of consecutive interruptions of the infrared monitoring beams.
Hemodynamic measurements
Hemodynamic studies were performed on rats under ketamine anesthesia (100 mg/kg body weight, intramuscularly administered). The right internal carotid artery was cannulated using a polyethylene PE-50 catheter connected to a Spectramed DTX transducer (Spectramed, Inc., Oxnard, CA, USA), and continuous recordings of MAP were made using a multichannel recorder (model RS 3400; Gould Inc., Cupertino, CA, USA). An external zero reference limit was placed at the midportion of each rat. The heart rate was determined from the recording. The abdomen was then opened with a midline incision, and the mesenteric vein was cannulated using a saline-filled PE-50 catheter for the sham-operated rats or an 18-G catheter for the PVL and BDL rats, which was connected to a Spectramed DTX transducer. The abdominal cavity was then closed, and the portal pressure was recorded using a Gould Model RS 3400 recorder. 15, 16 2.6. Flow-pressure curve study
The flow-pressure curve studies were performed using in situ-perfused portosystemic collaterals. When determining the flow-pressure curves, the perfusion flow rate increased by 3 mL/min, starting at 5 mL/min and climbing to 30 mL/min in the PVL rats and starting at 6 mL/min and climbing to 18 mL/ min in the BDL rats. Each new flow rate was allowed to stabilize for 3 minutes before the next higher flow rate was adjusted. The perfusion pressures were continuously recorded, and only one flow-pressure curve was performed for each preparation. The slope of a flow-pressure curve represents the overall resistance of the portosystemic collaterals and was regarded as the severity index of portosystemic shunting. 17, 18 A higher resistance indicates a lower degree of portosystemic shunting.
In situ perfusion of portosystemic collaterals
The in situ perfusion system was used as described in previous reports. 17e19 In brief, both jugular veins were cannulated using 16-gauge Teflon cannulas in order to ensure an adequate outflow without any resistance, even at high flow rates. Heparin (200 units/100g body weight) was injected through one of the cannulas. The abdomen was opened and an 18-gauge Teflon cannula was inserted into the distal mesenteric vein and used as the perfusate inlet. To exclude the liver from perfusion, a ligature was tied twice around the portal vein. The animal was then transferred to a warm chamber (37 AE 0.5 C). The temperature around the perfusion area was continuously monitored using a thermometer placed inside the mesentery and maintained at approximately 37 AE 0.5 C using a thermostatic pad and a temperature-controlled infrared lamp. An open-circuit perfusion was then started using Krebs solution (composed of the following [in mM]: NaCl, 118; KCl, 4.7; KH 2 PO 4 , 1.2; MgSO 4 , 1.2; CaCl 2 , 2.5; NaHCO 3 , 25; and dextrose 11.0; pH 7.4; 37 AE 0.5C) via a mesenteric cannula by a roller pump (model 505S; Watson-Marlow Limited, Falmouth, Cornwall, UK). The perfusate was equilibrated with carbogen gas (95% O 2, 5% CO 2 ) using a silastic membrane lung. 20 Both jugular vein cannulas were simultaneously opened in order to completely wash out the blood. Pneumothorax was created by opening slits in the diaphragm in order to increase resistance in the pulmonary arteries and prevent the perfusate from entering the left chambers of the heart. The portosystemic collaterals were then perfused with oxygenated (95% O 2 , 5% CO 2 ) Krebs solution containing 3% wt/vol albumin (factor V bovine serum albumin; Sigma, St. Louis, MO, USA). The effluent of the perfusion was collected in a reservoir and was not recirculated. In order to monitor and continuously record the pressure in the portosystemic collaterals, a Spectramed DTX transducer attached to a Gould model RS 3400 recorder was connected to a side arm and placed just proximal to the perfusion cannula with the zero placed at the level of the right atrium. Because the temperature and pressure of the system was stabilized within 20 minutes, all of the experiments were performed within 25 minutes after starting perfusion at a constant rate of 20 mL/minute (PVL rat) or 12 mL/minute (BDL rat).
Determination of plasma TNF-a levels
Plasma TNF-a levels were measured using a commercially available solid-phase sandwich enzyme-linked immunosorbent assay (rat TNFa kits; R & D Systems, Minneapolis, MN, USA) according to the protocol supplied by the manufacturer.
The standards and samples were incubated in a TNF-a antibody-coated 96-well microtiter plate. The wells were washed with buffer and then incubated with anti-TNF-a antibodies that had been conjugated to horseradish peroxidase for 2 hours. This was washed away, and a yellow-brownish color developed in the presence of the tetramethylbenzidine chromogen substrate. The intensity of the color was measured using a Bio-kinetics Reader (Bio-Tek Instruments, Inc., Winooski, VT, USA) in order to determine the absorbance at 450 nm with a corrected wavelength of 570 nm. The samples were compared against a standard curve in order to determine the amount of TNF-a present. All samples were run in duplicate. The lower limit of the TNF-a sensitivity of this assay was 5 pg/dL. The intra-and interassay coefficients of variation were 5.1% and 9.7%, respectively.
Determination of liver biochemistry parameters
Serum levels of ALT, AST, and total bilirubin were measured using a colorimetric assay (Daiichi Olympus AU 600; Olympus, Inc., Mizima, Japan).
Reagents
The reagents used to prepare the Krebs solution were purchased from Sigma (Sigma Chemical Co., St. Louis, MO, USA). All of the solutions were freshly prepared on the days of experiments.
Statistical analysis
The results are expressed as the means AE standard error of the mean (SEM). The flow-pressure curves were analyzed by linear regression. Statistical analyses were performed using the independent Student's t test and linear correlation analysis, as appropriate. The results were considered statistically significant if a p-value <0.05 was determined using the twotailed test. Table 1 shows the MAP, HR, and PP of the PVL, BDL, and corresponding control groups. Compared with the PVLcontrol group, PP was significantly higher ( p < 0.001) and MAP was significantly lower in the PVL group ( p ¼ 0.005). Similarly, PP in the BDL rats was significantly higher ( p < 0.001) and MAP was significantly lower in the BDL group ( p ¼ 0.048) than in the BDL-control group. There were no statistical differences in terms of HR between the PVL, BDL, and their corresponding control groups.
Results
Hemodynamic data of the study animals
Plasma TNF-a and liver biochemistry parameters
There were no significant differences between the PVL and PVL-control groups in terms of TNF-a (1.3 AE 0.7 vs. 1.2 AE 0.8 pg/mL, p ¼ 0.868), ALT (14.5 AE 3.7 vs. 14.8 AE 1.9 m/ L, p ¼ 0.943), and AST (96.6 AE 10.4 vs. 78.5 AE 6.1 m/L, p ¼ 0.161). Table 2 shows comparisons between the BDL and BDLcontrol groups. Plasma TNF-a, AST, and total bilirubin concentrations of the BDL group were significantly higher than those of the BDL-control group. In contrast, ALT levels were not significantly different between the BDL and BDLcontrol groups. 3.4. Degree of correlation between the extent of HE, flow-pressure curves, liver biochemistry parameters, and TNF-a levels
Motor activities
In both the PVL and BDL rats, there was no significant correlation between the motor activity counts and the slope of the flow-pressure curve (Fig. 2) . In BDL rats with significant HE, as indicated by decreased motor activities, a negative correlation was found between the motor activity count and the concentrations of various liver injury parameters, including AST ( p ¼ 0.007, R ¼ À0.595) and total bilirubin ( p ¼ 0.001, R ¼ À0.692, Fig. 3 ). Furthermore, a negative correlation was found between the TNF-a level and total movements in the BDL rats (Fig. 4) . No correlations were observed between motor activity counts, the concentrations of various liver injury parameters, and TNF-a levels in PVL rats ( p > 0.05).
Discussion
The pathogenesis of HE is complicated and not fully understood. 21, 22 However, insufficient liver functions and the presence of portosystemic collaterals, which result in the failure to metabolize toxic substances derived from the gastrointestinal tract, are considered fundamental to HE. Common animal models used to study HE include models of fulminant hepatic failure 23, 24 and portacaval shunts. 25, 26 To investigate the pathogenesis of HE, the early detection of neurological and behavioral disturbances in these animals is crucial. Our previous studies 27, 28 have demonstrated that the Opto-Varimex animal activity meter is a valid tool for the detection of motor activities in study animals. Based on the consecutive number of interruptions of the infrared monitoring beams, we were able to differentiate nonambulatory (e.g., scratching, gnawing, etc.) from ambulatory movements. In addition to horizontal movements, an additional row of infrared cells placed above this plane could provide more information on vertical movements. The results of the motor activity studies correlated with neurobehavioral scores. The portosystemic collateral perfusion model used in this study provides information on the degree of shunting. 17, 18 This is a highly sensitive and reproducible technique that can be used to evaluate the collateral vasculature. According to Poiseuille's Law, the amount of resistance in the collateral vascular bed can be used as an index of portosystemic shunting. This technique has demonstrated that the slope of the flow-pressure relationship (i.e., the collateral vascular resistance) decreases significantly and progressively 2e7 days after induction of portal hypertension in rats, 18 which is comparable to that measured using the microsphere method. 29 In addition, the nonrecirculating perfusion system excludes the influence of vasoactive substances that are released from anoxic organs during experiments. 19 In the present study, we used two animal modelsdBDL and PVL rats (representing animals that suffer from portosystemic collaterals, with or without liver failure, respectively)dto investigate the relationship between degrees of portosystemic shunting and changes in motor activities. We demonstrated that BDL rats have significantly more severe liver injuries and a higher level of TNF-a. In addition, their motor activities were significantly lower compared with those of the BDL-control group, which is compatible with the findings of previous studies. 27, 28 In contrast, the motor activities of the PVL group were not significantly different from those of the PVL-control group. These findings indicate that HE might not even occur in animals with a high degree of portosystemic collaterals and normal liver functions. Therefore, PVL model could not supersede other animal models for studying HE.
The current study reveals that the slope of the flow-pressure curve does not correlate with motor activity counts. Rather, in BDL rats with chronic liver injuries, AST and total bilirubin levels are correlated with motor activity counts. These findings suggest that portosystemic collaterals play a smaller role than liver functions when determining the severity of HE. However, we could not completely exclude the presence of collaterals as an additional factor that contributes to HE in cirrhotic rats. Collaterals divert toxic substances that elicit HE from the portal tributary blood flow into systemic circulation, and the study animals may have had a wide variation in their tolerance to the implicated substances.
It has been reported in recent years that the increased expression of TNF-a in the frontal cortex of rats following hepatic devascularization is correlated with the clinical progression of encephalopathy and brain edema. 30 In this study, there was a significant correlation between TNFa levels and motor activities in BDL and BDL-control rats. In other words, the higher the TNF-a concentration, the lower the motor activity counts. Our data are compatible with the results of a previous study that reported that cirrhotic patients with abnormal psychometric hepatic encephalopathy scores had higher TNF-a levels than those with normal scores. Furthermore, there was a significant correlation between psychometric hepatic encephalopathy scores and the TNF-a concentration. 31 This is further demonstrated by an animal study that reported that the onset of severe encephalopathy (e.g., coma) and brain edema in mice with azoxymethaneinduced acute liver failure were significantly delayed in TNF receptor-1 knockout mice. 32 Overall, therapies that target TNF-a may contribute to the amelioration of HE, but further clarification is required.
In conclusion, in rats with chronic liver injury and HE, liver function parameters, rather than the degree of shunting, were shown to correlate with motor activities. Portosystemic collaterals seem to play a less prominent role in determining the severity of HE. The significant correlation between circulating TNF-a levels and motor activity counts suggest the significant role that TNF-a plays in the development of HE.
